๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Continuous infusion of adriamycin + cyclophosphamide + 5-fluorouracil in disseminated breast cancer

โœ Scribed by V. Karasyeva; O. Zharkova; N. Promzeleva

Book ID
117666179
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
171 KB
Volume
34
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemoimmunotherapy of metast
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG
โœ Gabriel N. Hortobagyi; Jordan U. Gutterman; George R. Blumenschein; Charles K. T ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 619 KB

One hundred five patients with metastatic breast cancer were treated with 5-fluorouracil, Adriamycin, cyclophosphamide and BCG (FAC-BCG). The results were compared to those observed in a group of 44 patients treated with FAC chemotherapy alone. Although the overall response rates were similar (76% f

A randomized multicenter trial of cyclop
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
โœ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-